Dr. Soon-Shiong, Gary reports, will also be on Fox News Special Report at 6 pm ET Friday.

Couldn't agree more with Right to Try, Sen Johnson. & those patients who have diseases that aren't rare but have no effective FDA-approved treatments should have a right to try as well. Senator Ron Johnson Secretary Kennedy

NIH Director Dr. Jay Bhattacharya saying Covid vaccine-injured patients have been “gaslit” is a big step toward change. In my book, I investigated the only NIH study to treat these patients. It concluded nearly all had recovered. But in fact they didn’t recover: They told me

Dr. Soon-Shiong is on Fox News next, after the commercials. It's 6:25 ET now.

For those who missed reporter Chris Cuomo's show "Why Can't We Cure Cancer?" w, among others, Drs. Patrick Soon-Shiong & Jay Bhattacharya, former FDA Associate Commissioner Peter Pitts & patients, including those cured w Anktiva: Here's the link to the entire episode:

Dr. Soon-Shiong meets w NIH Director Jay Bhattacharya & NCI Director Tony Letai to discuss science underlying PSS's work on IL-15 & the decade of Anktiva trials. Meetings like this w people in charge may indicate, at long last, change is coming. Wouldn't that be beautiful?

Is this another piece in the cancer/virus puzzle? Do we need to strengthen NK cells by raising glutathione levels? Do we need more of the stuff that makes glutathione, including sulfur vegetables; cysteine from eggs, fish, whey protein; & a direct cysteine source, NAC?

$IBRX 👀

Surgery for Braelyn, 18, is Thurs at UCLA to remove recurrent glioblastoma. The tumor tissue will be used to create a personal dendritic cell vaccine 4 her. Dendritic cells r sentinels, alert 4 bad guys who shouldn't be around--cancers, viruses, etc. Once they detect invaders,

After just 2 Anktiva treatments at Dr. Soon-Shiong's clinic, CarnivoreKen's Absolute Lymphocyte Count has improved. Ken has head/neck squamous cell cancer from HPV. 1st labs before 2nd treatment. 2nd labs, before 3rd treatment. Two of the improved numbers, below: Dr. Pat Soon-Shiong

Favorite moment in Chris Cuomo's show: When uninformed Dr. Karen Knudsen of the Parker Cancer Institute hasn't gotten the Anktiva memo. Dr. Soon-Shiong schools her about the IL-15 protein our bodies make to stimulate NK cells to kill cancer. His 10 yrs of studies have resulted

Some PubMed studies don't use the word "Anktiva," or only in passing. They prefer Anktiva's birth name, N-803 or N803. Some studies may be hidden that way. Here's my thinking, Ed. As you know, Anktiva works for patients w both papillary & CIS bladder tumors. Yet FDA hasn't

4 dates in March concerning Dr. Soon-Shiong's Anktiva to watch for. The 1st date is Fri, March 6:

Braelyn, 18, is getting surgery today at UCLA 4 recurrent glioblastoma. The tumor tissue will be used to create a personal dendritic cell vaccine 4 her to fight what cancer cells remain. Dendritic cells detect cancers/viruses & then present pieces of them to cells that can

Braelyn's UCLA brain surgery to remove a tumor could not have gone better. While they knew in advance that not all of the tumor could be removed, 90% was excised. After surgery, the tumor swelling deflated back to normal, which should improve Braelyn's symptoms. The surgeon,

Rachel, FDA is listening. But it's not rushing to approve AMT-130 for Huntington's, the genetic, always-fatal degenerative brain disease, because it's made by a small Dutch company. That's the same reason FDA hasn't rushed to approve Anktiva for more than 1 form of bladder

As Macro Ghost reports, w Dr. Vinay Prasad exiting the FDA division that reviews immunotherapies, including Anktiva, this could be good news for Dr. Soon Shiong: Prasad isn't a fan of Anktiva.

Would Dr. Patrick Soon-Shiong's drug Anktiva, already approved for 1 kind of bladder cancer, work 4 ME? Anktiva boosts NK cell number & function. It's in trials now 4 long Covid & many cancers. Most ME patients have low & dysfunctional Natural Killer (NK) cells, which kill